Back to Search
Start Over
Networks of blood proteins in the neuroimmunology of schizophrenia
- Source :
- Translational Psychiatry, Vol 8, Iss 1, Pp 1-10 (2018), Translational psychiatry, vol. 8, no. 1, pp. 112, Translational psychiatry, vol 8, iss 1, Translational Psychiatry
- Publication Year :
- 2018
- Publisher :
- Springer Science and Business Media LLC, 2018.
-
Abstract
- Levels of certain circulating cytokines and related immune system molecules are consistently altered in schizophrenia and related disorders. In addition to absolute analyte levels, we sought analytes in correlation networks that could be prognostic. We analyzed baseline blood plasma samples with a Luminex platform from 72 subjects meeting criteria for a psychosis clinical high-risk syndrome; 32 subjects converted to a diagnosis of psychotic disorder within two years while 40 other subjects did not. Another comparison group included 35 unaffected subjects. Assays of 141 analytes passed early quality control. We then used an unweighted co-expression network analysis to identify highly correlated modules in each group. Overall, there was a striking loss of network complexity going from unaffected subjects to nonconverters and thence to converters (applying standard, graph-theoretic metrics). Graph differences were largely driven by proteins regulating tissue remodeling (e.g. blood-brain barrier). In more detail, certain sets of antithetical proteins were highly correlated in unaffected subjects (e.g. SERPINE1 vs MMP9), as expected in homeostasis. However, for particular protein pairs this trend was reversed in converters (e.g. SERPINE1 vs TIMP1, being synthetical inhibitors of remodeling of extracellular matrix and vasculature). Thus, some correlation signals strongly predict impending conversion to a psychotic disorder and directly suggest pharmaceutical targets.
- Subjects :
- Male
0301 basic medicine
Correlation
Adolescent
Adult
Biomarkers
Blood Proteins
Female
Humans
Longitudinal Studies
Matrix Metalloproteinase 9
Neuroimmunomodulation
Plasminogen Activator Inhibitor 1
Schizophrenia
Tissue Inhibitor of Metalloproteinase-1
Young Adult
Psychiatry and Mental Health
Cellular and Molecular Neuroscience
Biological Psychiatry
0302 clinical medicine
Blood plasma
2.1 Biological and endogenous factors
Psychology
Aetiology
Serious Mental Illness
Blood proteins
Psychiatry and Mental health
Mental Health
Public Health and Health Services
medicine.medical_specialty
Psychosis
Biomarkers/blood
Blood Proteins/analysis
Matrix Metalloproteinase 9/blood
Plasminogen Activator Inhibitor 1/blood
Schizophrenia/blood
Schizophrenia/diagnosis
Schizophrenia/immunology
Tissue Inhibitor of Metalloproteinase-1/blood
Clinical Sciences
Article
lcsh:RC321-571
03 medical and health sciences
Text mining
Clinical Research
Internal medicine
medicine
lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry
business.industry
Neurosciences
medicine.disease
Brain Disorders
030104 developmental biology
Endocrinology
Neuroimmunology
business
030217 neurology & neurosurgery
Homeostasis
Subjects
Details
- ISSN :
- 21583188
- Volume :
- 8
- Database :
- OpenAIRE
- Journal :
- Translational Psychiatry
- Accession number :
- edsair.doi.dedup.....124003319a041c02fec086d01d59eb1f
- Full Text :
- https://doi.org/10.1038/s41398-018-0158-y